C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2001
10/16/2001	US6303333 Expression vector which codes polypeptides for the diagnosis and treatment of cancer, dietetics, inflammation, cardiovascular disorders, crohn's diseases, neuropathies and immune defects
10/16/2001	US6303331 Vertebrate apoptosis gene: compositions and methods
10/16/2001	US6303321 Methods for diagnosing sepsis
10/16/2001	US6303313 Method for generating libraries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
10/16/2001	US6303297 Apparatus storing and evaluating nucleotide sequences; for diagnosis and detection of genotype defects
10/16/2001	US6303292 Geneticlly engineered viral polypeptides; for use in diagnosis and treatment of viral infection
10/16/2001	US6303121 Method of using human receptor protein 4-1BB
10/16/2001	US6303120 Inducing antibodies in a subject to an allyl-substituted pentasaccharide by administering the compound conjugated to a protein carrier at its allyl group.
10/16/2001	US6303118 Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases
10/16/2001	CA2044626C Type a platelet-derived growth factor receptor gene
10/16/2001	CA2036463C Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines
10/16/2001	CA2001774C Method for identifying active domains and amino acid residues in polypeptides and hormone variants
10/16/2001	CA1341305C Dna binding proteins including androgen receptor
10/11/2001	WO2001075454A2 Diagnosis and treatment of alzheimer's disease
10/11/2001	WO2001075453A2 Methods involving induced dimerisation by cellular components
10/11/2001	WO2001075448A2 Methods and compositions for detecting larval taenia solium with a cloned diagnostic antigen
10/11/2001	WO2001075441A1 Method for diagnosing cancerous diseases and/or neuro-degenerative pathological conditions and products therefor
10/11/2001	WO2001075440A2 Schizophrenia related genes
10/11/2001	WO2001075110A2 Mucin-1 specific binding members and methods of use thereof
10/11/2001	WO2001075109A2 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability
10/11/2001	WO2001075107A2 Use of p-selectin glycoprotein ligand-1 (psgl-1) and fragments thereof for the inhibition of thrombosis
10/11/2001	WO2001075097A2 Improvements to ribosome display
10/11/2001	WO2001075091A2 A method for in vitro molecular evolution of antibody function
10/11/2001	WO2001075087A2 Subtilisin variants
10/11/2001	WO2001075082A1 DEOXYRIBONUCLEASE IIβ PROTEINS AND cDNAs
10/11/2001	WO2001075078A1 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS
10/11/2001	WO2001075074A1 Novel proteins
10/11/2001	WO2001075064A2 Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides
10/11/2001	WO2001074905A1 Compounds for targeting
10/11/2001	WO2001074904A2 G-protein coupled receptors and nucleic acids encoding same
10/11/2001	WO2001074903A2 CD20/IgE-RECEPTOR LIKE MOLECULES AND USES THEREOF
10/11/2001	WO2001074896A1 Human polynucleotides, polypeptides, and antibodies
10/11/2001	WO2001074892A1 A novel polypeptide-human prostate-specific membrane antibody protein 12 and a polynucleotide encoding the same
10/11/2001	WO2001074884A1 Dermacentor variabilis gaba-gated chloride channels
10/11/2001	WO2001074859A2 A gene differentially expressed in breast and bladder cancer and encoded polypeptides
10/11/2001	WO2001074856A2 Wnt-7b-like polypeptides and nucleic acids encoding same
10/11/2001	WO2001074841A1 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis
10/11/2001	WO2001074388A1 Combined use of anti-cytokine antibodies or antagonists and anti-cd20 for the treatment of b cell lymphoma
10/11/2001	WO2001074299A2 Compositions and methods for inhibition of cancer invasion and angiogenesis
10/11/2001	WO2001074296A2 Treatment of non-solid mammalian tumors with vascular endothelial growth factor receptor antagonists
10/11/2001	WO2001066139A8 Use of a compound that selectively binds to cd123 to impair hematologic cancer progenitor cell
10/11/2001	WO2001045746A3 Methods and compositions for prolonging elimination half-times of bioactive compounds
10/11/2001	WO2001040268A3 Beryllofluoride analogues of acyl phosphate polypeptides
10/11/2001	WO2001036640A3 Human fgf-21 gene and gene expression products
10/11/2001	WO2001032702A9 Molecular structure of rhd negative locus
10/11/2001	WO2001031003B1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response
10/11/2001	WO2001027612A3 Immuno-chromatographic rapid assay in order to detect acid-resistant microorganisms in the stool
10/11/2001	WO2001025269A3 Human g-protein coupled receptor
10/11/2001	WO2001024763A3 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
10/11/2001	WO2001022994A3 Vaccines against neisseria infection
10/11/2001	WO2001021799B1 Traf4 associated cell cycle proteins, compositions and methods of use
10/11/2001	WO2001021202A3 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells
10/11/2001	WO2001020025A3 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications
10/11/2001	WO2001007470A3 Human nervous system-associated proteins
10/11/2001	WO2000063382A9 Genes and expression products from hematopoietic cells
10/11/2001	WO2000026240A3 Streptococcal alpha2m-binding protein
10/11/2001	US20010029293 Icam-related protein
10/11/2001	US20010029292 Sepsis
10/11/2001	US20010029045 Lineage restricted glial precursors from the central nervous system
10/11/2001	US20010029031 Polynucleotides encoding human sodium bicarbonate cotransporters
10/11/2001	US20010029030 Novel trail receptors, nucleic acids encoding same, and methods of use thereof
10/11/2001	US20010028883 Papillomavirus cellular receptor
10/11/2001	US20010028882 Anti-cryptosporidium parvum preparations
10/11/2001	US20010028881 Determination concentrtaion
10/11/2001	DE10017250A1 Preparing RiV-optimized vaccines and blood products, useful in human and veterinary medicine, giving products that contain RiV particles or anti-RiV antibodies
10/11/2001	DE10013619A1 New polypeptide subunit of invertebrate ligand-controlled anion channel, useful in screening for potential plant-protection agents, especially insecticides
10/11/2001	CA2413211A1 A gene differentially expressed in breast and bladder cancer and encoded polypeptides
10/11/2001	CA2405063A1 Subtilisin variants
10/11/2001	CA2404576A1 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability
10/11/2001	CA2404572A1 Inhibition of thrombosis by treatment with p-selectin antagnosits
10/11/2001	CA2404541A1 G-protein coupled receptors and nucleic acids encoding same
10/11/2001	CA2404526A1 Protein amf-1 to amf-10 and nucleic acids encoding the same
10/11/2001	CA2404519A1 Wnt-7b-like polypeptides and nucleic acids encoding same
10/11/2001	CA2404501A1 Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides
10/11/2001	CA2404484A1 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis
10/11/2001	CA2404365A1 Combined use of anti-cytokine antibodies or antagonists and anti-cd20 for the treatment of b cell lymphoma
10/11/2001	CA2404074A1 Human polynucleotides, polypeptides, and antibodies
10/11/2001	CA2404040A1 Treatment of non-solid mammalian tumors with vascular endothelial growth factor receptor antagonists
10/11/2001	CA2403998A1 Mucin-1 specific binding members and methods of use thereof
10/11/2001	CA2402452A1 Improvements to ribosome display
10/11/2001	CA2401948A1 Cd20/ige-receptor like molecules and uses thereof
10/11/2001	CA2399934A1 Methods involving induced dimerisation by cellular components
10/10/2001	EP1143250A2 Test methods and devices for analyte isoforms
10/10/2001	EP1143249A2 Test methods and devices for analyte isoforms
10/10/2001	EP1143006A2 Vectors/DNA-sequences from human combinatorial antibody libraries
10/10/2001	EP1142996A1 Monoclonal antibody against apolipoprotein a-i
10/10/2001	EP1142995A1 Antiuracil monoclonal antibody
10/10/2001	EP1142991A2 Monoclonal antibodies to thymidine kinase isozymes
10/10/2001	EP1142910A1 Inhibitors for the formation of soluble human CD23
10/10/2001	EP1141727A2 Early pregnancy diagnosis using pags (pregnancy-associated glycoproteins)
10/10/2001	EP1141723A1 Treatment and diagnosis of cancer using inositolphosphoglycans antagonists
10/10/2001	EP1141389A2 Reagents and methods useful for detecting diseases of the breast
10/10/2001	EP1141376A1 Peptidoglycan recognition proteins
10/10/2001	EP1141366A1 Transfectacons comprising calcium phosphate and a nucleic acid
10/10/2001	EP1141353A2 Plant cell cycle genes and uses thereof
10/10/2001	EP1141332A1 Human cyclic nucleotide pdes
10/10/2001	EP1141331A2 HUMAN CYCLIN-DEPENDENT KINASE (hPNQALRE)
10/10/2001	EP1141326A2 Human akt-3
10/10/2001	EP1141325A1 Ikk3 kinase
10/10/2001	EP1141316A1 Hepatitis y virus

1 ... 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 ... 1494